Fresh Tracks Therapeutics, Inc. (FRTX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
5777 CENTRAL AVENUE BOULDER, CO 80301 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 8,680 | 26,884 | 30,115 | 11,700 | 48,071 | 60,499 | |||
| Cash and cash equivalents | 8,680 | 26,884 | 30,115 | 7,232 | 11,870 | 24,841 | |||
| Short-term investments | 4,497 | 36,201 | 35,658 | ||||||
| Other undisclosed cash, cash equivalents, and short-term investments | (29) | ||||||||
| Restricted cash and investments | 192 | ||||||||
| Receivables | 250 | 1,128 | 5,124 | ||||||
| Prepaid expense | 638 | ||||||||
| Contract with customer, asset, after allowance for credit loss | 254 | ✕ | |||||||
| Deferred costs | 10,502 | ||||||||
| Other current assets | 7 | ||||||||
| Other undisclosed current assets | 254 | 2,716 | 3,415 | 6,269 | |||||
| Total current assets: | 10,083 | 29,600 | 33,530 | 17,969 | 49,199 | 76,317 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 49 | 59 | 74 | 159 | ✕ | ✕ | |||
| Property, plant and equipment | 75 | 58 | 30 | 16 | 100 | 606 | |||
| Long-term investments and receivables | 2,386 | 2,209 | |||||||
| Long-term investments | 2,386 | 2,209 | |||||||
| Intangible assets, net (including goodwill) | 703 | ||||||||
| Intangible assets, net (excluding goodwill) | 703 | ||||||||
| Contract with customer, asset, after allowance for credit loss | 64 | ✕ | |||||||
| Other noncurrent assets | 659 | 659 | |||||||
| Total noncurrent assets: | 188 | 117 | 104 | 175 | 3,145 | 4,177 | |||
| TOTAL ASSETS: | 10,271 | 29,717 | 33,634 | 18,144 | 52,344 | 80,494 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 3,028 | 4,741 | 5,988 | 8,624 | 3,551 | 5,217 | |||
| Employee-related liabilities | ✕ | ✕ | 1,768 | 2,654 | |||||
| Accounts payable | 571 | 1,605 | 568 | 2,245 | 412 | 1,213 | |||
| Accrued liabilities | 2,457 | 3,136 | 5,420 | 6,379 | 371 | 333 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,000 | 1,017 | |||||||
| Deferred revenue | 1,795 | ✕ | ✕ | ||||||
| Debt | 291 | 78 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 11,700 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 30 | ✕ | ||
| Other undisclosed current liabilities | 49 | 69 | 74 | ||||||
| Total current liabilities: | 3,077 | 4,810 | 6,353 | 10,497 | 3,581 | 16,917 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 146 | 73 | |||||||
| Long-term debt, excluding current maturities | 146 | ||||||||
| Operating lease, liability | 73 | ✕ | ✕ | ||||||
| Total noncurrent liabilities: | 146 | 73 | |||||||
| Total liabilities: | 3,077 | 4,810 | 6,499 | 10,570 | 3,581 | 16,917 | |||
| Equity | |||||||||
| Equity, attributable to parent | 7,194 | 24,907 | 27,135 | 7,574 | 48,763 | 63,577 | |||
| Common stock | 30 | 1,194 | 536 | 85 | 218 | 218 | |||
| Additional paid in capital | 173,633 | 169,080 | 132,492 | 92,497 | 490,337 | 489,975 | |||
| Accumulated other comprehensive income (loss) | (28) | 272 | 122 | ||||||
| Accumulated deficit | (166,469) | (145,367) | (105,893) | (84,980) | (442,064) | (426,738) | |||
| Total equity: | 7,194 | 24,907 | 27,135 | 7,574 | 48,763 | 63,577 | |||
| TOTAL LIABILITIES AND EQUITY: | 10,271 | 29,717 | 33,634 | 18,144 | 52,344 | 80,494 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,943 | 404 | 1,822 | 7,917 | 1,622 | 13,819 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 13,401 | |
| Cost of revenue | (2,231) | (6,479) | ||||||
| Cost of goods and services sold | (1,436) | (6,479) | ||||||
| Gross profit: | 6,943 | 404 | 1,822 | 7,917 | (609) | 7,340 | ||
| Operating expenses | (28,477) | (40,648) | (22,798) | (32,385) | (19,037) | (20,726) | ||
| Operating loss: | (21,534) | (40,244) | (20,976) | (24,468) | (19,646) | (13,386) | ||
| Nonoperating income | 441 | 839 | 63 | 157 | 3,392 | 426 | ||
| Investment income, nonoperating | 441 | 839 | 63 | 157 | ||||
| Interest and debt expense | (9) | (69) | 222 | |||||
| Loss from continuing operations: | (21,102) | (39,474) | (20,913) | (24,089) | (16,254) | (12,960) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (39,474) | (20,913) | (24,089) | (16,254) | (12,960) | |
| Net loss: | (21,102) | (39,474) | (20,913) | (24,089) | (16,254) | (12,960) | ||
| Other undisclosed net income attributable to parent | 212 | |||||||
| Net loss attributable to parent: | (21,102) | (39,474) | (20,913) | (23,877) | (16,254) | (12,960) | ||
| Preferred stock dividends and other adjustments | 10,274 | |||||||
| Net loss available to common stockholders, diluted: | (21,102) | (39,474) | (20,913) | (13,603) | (16,254) | (12,960) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (21,102) | (39,474) | (20,913) | (24,089) | (16,254) | (12,960) | ||
| Other comprehensive income | 2,263 | 150 | 97 | |||||
| Comprehensive loss: | (21,102) | (37,211) | (20,913) | (24,089) | (16,104) | (12,863) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2,263) | 28 | 184 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (21,102) | (39,474) | (20,885) | (23,905) | (16,104) | (12,863) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.